peptic ulcer disease |
Disease ID | 828 |
---|---|
Disease | peptic ulcer disease |
Manually Symptom | (Waiting for update.) |
Text Mined Symptom | UMLS | Name | Sentences' Count(Total Symptoms:9) C0009450 | infection | 7 C0024623 | gastric cancer | 6 C0267373 | intestinal bleeding | 3 C0001173 | gastric outlet obstruction | 2 C0017152 | gastritis | 2 C0014868 | esophagitis | 1 C0850666 | h. pylori infection | 1 C0267055 | erosive esophagitis | 1 C0850666 | helicobacter pylori infection | 1 |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
All Snps(Total Genotypes:22) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
rs10306114 | 17078001 | 5742 | PTGS1 | umls:C0030920 | BeFree | The COX-1 A-842G/C50T SNP does not influence the risk for developing peptic ulcer bleeding. | 0.008458305 | 2006 | PTGS1 | 9 | 122370243 | A | G |
rs1045642 | 18644389 | 5243 | ABCB1 | umls:C0030920 | BeFree | MDR1 C3435T polymorphism has no influence on developing Helicobacter pylori infection-related gastric cancer and peptic ulcer in Japanese. | 0.008729747 | 2008 | ABCB1 | 7 | 87509329 | A | T,G |
rs1045642 | 24815441 | 5243 | ABCB1 | umls:C0030920 | BeFree | Lack of association of the MDR1 C3435T polymorphism with susceptibility to gastric cancer and peptic ulcer: a systemic review and meta-analysis. | 0.008729747 | 2015 | ABCB1 | 7 | 87509329 | A | T,G |
rs1045642 | 22001987 | 5243 | ABCB1 | umls:C0030920 | BeFree | C3435T polymorphism of the ABCB1 gene: impact on genetic susceptibility to peptic ulcers. | 0.008729747 | 2011 | ABCB1 | 7 | 87509329 | A | T,G |
rs10509681 | 23267857 | 1559 | CYP2C9 | umls:C0030920 | BeFree | We investigated whether eight functional SNPs in the CYP2C family of genes--CYP2C8*3 (rs11572080 and rs10509681), CYP2C8*4, CYP2C9*2, CYP2C9*3, CYP2C19*2, CYP2C19*3, and CYP2C19*17--are associated with PUD in 1,239 Caucasian patients. | 0.005276948 | 2013 | CYP2C8 | 10 | 95038992 | T | C |
rs10509681 | 23267857 | 1558 | CYP2C8 | umls:C0030920 | BeFree | We investigated whether eight functional SNPs in the CYP2C family of genes--CYP2C8*3 (rs11572080 and rs10509681), CYP2C8*4, CYP2C9*2, CYP2C9*3, CYP2C19*2, CYP2C19*3, and CYP2C19*17--are associated with PUD in 1,239 Caucasian patients. | 0.000271442 | 2013 | CYP2C8 | 10 | 95038992 | T | C |
rs11572080 | 23267857 | 1559 | CYP2C9 | umls:C0030920 | BeFree | We investigated whether eight functional SNPs in the CYP2C family of genes--CYP2C8*3 (rs11572080 and rs10509681), CYP2C8*4, CYP2C9*2, CYP2C9*3, CYP2C19*2, CYP2C19*3, and CYP2C19*17--are associated with PUD in 1,239 Caucasian patients. | 0.005276948 | 2013 | CYP2C8 | 10 | 95067273 | C | T |
rs11572080 | 23267857 | 1558 | CYP2C8 | umls:C0030920 | BeFree | We investigated whether eight functional SNPs in the CYP2C family of genes--CYP2C8*3 (rs11572080 and rs10509681), CYP2C8*4, CYP2C9*2, CYP2C9*3, CYP2C19*2, CYP2C19*3, and CYP2C19*17--are associated with PUD in 1,239 Caucasian patients. | 0.000271442 | 2013 | CYP2C8 | 10 | 95067273 | C | T |
rs11614913 | 21073609 | 406938 | MIR146A | umls:C0030920 | BeFree | We evaluated the associations of three SNPs (rs11614913, rs2910164, and rs3746444) in pre-miRNAs (miR-196a2, miR-146a, and miR-499) with the risk of gastric cancer (GC) and peptic ulcer diseases, and with the severity of Helicobacter pylori-induced gastritis in Japanese population. | 0.000271442 | 2010 | MIR196A2 | 12 | 53991815 | C | T |
rs11614913 | 21073609 | 574501 | MIR499A | umls:C0030920 | BeFree | We evaluated the associations of three SNPs (rs11614913, rs2910164, and rs3746444) in pre-miRNAs (miR-196a2, miR-146a, and miR-499) with the risk of gastric cancer (GC) and peptic ulcer diseases, and with the severity of Helicobacter pylori-induced gastritis in Japanese population. | 0.000271442 | 2010 | MIR196A2 | 12 | 53991815 | C | T |
rs1330344 | 25243161 | 5742 | PTGS1 | umls:C0030920 | BeFree | Impact of blood type, functional polymorphism (T-1676C) of the COX-1 gene promoter and clinical factors on the development of peptic ulcer during cardiovascular prophylaxis with low-dose aspirin. | 0.008458305 | 2014 | PTGS1 | 9 | 122369409 | C | T |
rs1799964 | 25368751 | 7124 | TNF | umls:C0030920 | BeFree | TNFA-308G>A (rs1800629) and TNFA-1031T>C (rs1799964), which are responsible for increased TNFA transcription, could influence the risk of peptic ulceration. | 0.016731045 | 2013 | LTA;TNF;LOC100287329 | 6 | 31574531 | T | C |
rs1800629 | 25368751 | 7124 | TNF | umls:C0030920 | BeFree | TNFA-308G>A (rs1800629) and TNFA-1031T>C (rs1799964), which are responsible for increased TNFA transcription, could influence the risk of peptic ulceration. | 0.016731045 | 2013 | TNF | 6 | 31575254 | G | A |
rs1801282 | 18372284 | 5468 | PPARG | umls:C0030920 | BeFree | The study suggests that Pro12Ala PPARgamma polymorphism is associated with gastric adenocarcinoma and PUD, and is a potential marker for genetic susceptibility to these two diseases in the presence of H. pylori infection. | 0.005362824 | 2008 | PPARG | 3 | 12351626 | C | G |
rs1805192 | 18372284 | 5468 | PPARG | umls:C0030920 | BeFree | The study suggests that Pro12Ala PPARgamma polymorphism is associated with gastric adenocarcinoma and PUD, and is a potential marker for genetic susceptibility to these two diseases in the presence of H. pylori infection. | 0.005362824 | 2008 | PPARG | 3 | 12379739 | C | G |
rs2075820 | 17309748 | 7099 | TLR4 | umls:C0030920 | BeFree | E266K CARD4/NOD1, but not the TLR4 gene polymorphism increases the risk of peptic ulceration in H. pylori-positive patients. | 0.000271442 | 2007 | NOD1 | 7 | 30452621 | C | T |
rs2075820 | 17309748 | 10392 | NOD1 | umls:C0030920 | BeFree | E266K CARD4/NOD1, but not the TLR4 gene polymorphism increases the risk of peptic ulceration in H. pylori-positive patients. | 0.000542884 | 2007 | NOD1 | 7 | 30452621 | C | T |
rs2910164 | 21073609 | 406938 | MIR146A | umls:C0030920 | BeFree | We evaluated the associations of three SNPs (rs11614913, rs2910164, and rs3746444) in pre-miRNAs (miR-196a2, miR-146a, and miR-499) with the risk of gastric cancer (GC) and peptic ulcer diseases, and with the severity of Helicobacter pylori-induced gastritis in Japanese population. | 0.000271442 | 2010 | LOC285628;MIR146A | 5 | 160485411 | C | G |
rs2910164 | 21073609 | 574501 | MIR499A | umls:C0030920 | BeFree | We evaluated the associations of three SNPs (rs11614913, rs2910164, and rs3746444) in pre-miRNAs (miR-196a2, miR-146a, and miR-499) with the risk of gastric cancer (GC) and peptic ulcer diseases, and with the severity of Helicobacter pylori-induced gastritis in Japanese population. | 0.000271442 | 2010 | LOC285628;MIR146A | 5 | 160485411 | C | G |
rs3746444 | 21073609 | 574501 | MIR499A | umls:C0030920 | BeFree | We evaluated the associations of three SNPs (rs11614913, rs2910164, and rs3746444) in pre-miRNAs (miR-196a2, miR-146a, and miR-499) with the risk of gastric cancer (GC) and peptic ulcer diseases, and with the severity of Helicobacter pylori-induced gastritis in Japanese population. | 0.000271442 | 2010 | MYH7B;MIR499A;MIR499B | 20 | 34990448 | A | G |
rs3746444 | 21073609 | 406938 | MIR146A | umls:C0030920 | BeFree | We evaluated the associations of three SNPs (rs11614913, rs2910164, and rs3746444) in pre-miRNAs (miR-196a2, miR-146a, and miR-499) with the risk of gastric cancer (GC) and peptic ulcer diseases, and with the severity of Helicobacter pylori-induced gastritis in Japanese population. | 0.000271442 | 2010 | MYH7B;MIR499A;MIR499B | 20 | 34990448 | A | G |
rs3842787 | 17078001 | 5742 | PTGS1 | umls:C0030920 | BeFree | The COX-1 A-842G/C50T SNP does not influence the risk for developing peptic ulcer bleeding. | 0.008458305 | 2006 | PTGS1 | 9 | 122371228 | C | T |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:0) |
---|
(Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
---|
(Waiting for update.) |
Chemical(Total Drugs:13) | |||||||||
---|---|---|---|---|---|---|---|---|---|
CUI | ChemicalName | ChemicalID | CasRN | DiseaseName | DiseaseID | DirectEvidence | PubMedIDs | ||
C0030920 | atropine | D001285 | 51-55-8 | peptic ulcer | MESH:D010437 | therapeutic | 7034155 | ||
C0030920 | celecoxib | D000068579 | - | peptic ulcer | MESH:D010437 | marker/mechanism | 16897817 | ||
C0030920 | cimetidine | D002927 | 51481-61-9 | peptic ulcer | MESH:D010437 | therapeutic | 11421865 | ||
C0030920 | diclofenac | D004008 | 15307-86-5 | peptic ulcer | MESH:D010437 | marker/mechanism | 16897817 | ||
C0030920 | indomethacin | D007213 | 53-86-1 | peptic ulcer | MESH:D010437 | marker/mechanism | 11148446 | ||
C0030920 | lansoprazole | D064747 | - | peptic ulcer | MESH:D010437 | therapeutic | 11394734 | ||
C0030920 | omeprazole | D009853 | 73590-58-6 | peptic ulcer | MESH:D010437 | marker/mechanism | 8667442 | ||
C0030920 | omeprazole | D009853 | 73590-58-6 | peptic ulcer | MESH:D010437 | therapeutic | 10192720 | ||
C0030920 | pantoprazole | C064276 | 102625-70-7 | peptic ulcer | MESH:D010437 | therapeutic | 19837071 | ||
C0030920 | piroxicam | D010894 | 36322-90-4 | peptic ulcer | MESH:D010437 | marker/mechanism | 2957207 | ||
C0030920 | spironolactone | D013148 | 1952/1/7 | peptic ulcer | MESH:D010437 | therapeutic | 5569832 | ||
C0030920 | sucralfate | D013392 | 54182-58-0 | peptic ulcer | MESH:D010437 | marker/mechanism | 8667442 | ||
C0030920 | tinidazole | D014011 | 19387-91-8 | peptic ulcer | MESH:D010437 | therapeutic | 11394734 |
FDA approved drug and dosage information(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA labeling changes(Total Drugs:0) | |
---|---|
(Waiting for update.) |